OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 10 citing articles:

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 301

Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients With Hodgkin Lymphoma
Jenica N. Upshaw, Jason Nelson, Benjamin Sweigart, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 200-213
Open Access | Times Cited: 4

Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma
Agata Marjańska, Katarzyna Pawińska-Wąsikowska, Aleksandra Wieczorek, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 968-968
Open Access | Times Cited: 3

Comparative Study of Nanoparticle Blood Circulation after Forced Clearance of Own Erythrocytes (Mononuclear Phagocyte System-Cytoblockade) or Administration of Cytotoxic Doxorubicin- or Clodronate-Loaded Liposomes
Elizaveta N. Mochalova, E. A. Egorova, Kristina S. Komarova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10623-10623
Open Access | Times Cited: 8

Hodgkin lymphoma treatment for older persons in the modern era
Andrew M. Evens, Marshall McKenna, Yun Kyoung Tiger, et al.
Hematology (2023) Vol. 2023, Iss. 1, pp. 483-499
Closed Access | Times Cited: 4

Liposomal‐encapsulated doxorubicin supercharge‐containing front‐line treatment improves response rates in primary mediastinal large B‐cell lymphoma and mediastinal gray zone lymphoma
Marco Picardi, Claudia Giordano, Novella Pugliese, et al.
Hematological Oncology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 1

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
Arina Martynchyk, Rakin Chowdhury, Eliza A. Hawkes, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5217-5217
Open Access | Times Cited: 2

Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview
Wellington Francisco Rodrigues, Camila Botelho Miguel, Melissa Carvalho Martins de Abreu, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5299-5299
Open Access | Times Cited: 1

Page 1

Scroll to top